Tumor necrosis factor-α and interleukin-1β increase the Fas-mediated apoptosis of human osteoblasts

Journal of Laboratory and Clinical Medicine

Volumn 134, Issue 3, 1999, Pages 222-231

  Tsuboi, Masahiko ^b   Kawakami, Atsushi ^b   Nakashima, Tomoki ^b   Matsuoka, Naoki ^b   Urayama, Satoshi ^b   Kawabe, Yojiro ^b   Fujiyama, Kaoru ^b   Kiriyama, Takeshi ^b   Aoyagi, Takahiko ^b   Maeda, Kenji ^b   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033199486     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90201-9     Document Type: Article

References (38)

1. 1. Rodan GA, Rodan SB. The cells of bone. In: Riggs BL, Melton LJ III, editors. Osteoporosis: etiology, diagnosis, and management. 2nd ed. Philadelphia: Lippincott-Raven Publishers; 1995. p. 1-39.
2. 2. Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N. Modulation of osteoclast differentiation by local factors. Bone 1995;17(suppl 2):875-915.
3. 3. Manolagas SC. Role of cytokines in bone resorption. Bone 1995;17(suppl 2):635-75.
4. 4. Ishimi Y, Miyaura C, Cheng HJ, Akatsu T, Abe E, Nakamura Y, et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;145:3297-303.
5. 5. Lerner UH, Ohlin A. Tumor necrosis factors α can stimulate bone resorption in cultured mouse calvariae by a prostaglandin-independent mechanism. J Bone Miner Res 1993;8:147-55.
6. 6. Manolagas SC. Role of cytokines in bone resorption. Bone 1995;17(suppl):63s-7.
7. 7. Kitajima I, Shao Q, Socjima Y, Maruyama I. Ceramide-induced AP-1 activation is a mediator of apoptotic response to TNF-α in periarticular osteoblasts in patients with rheumatoid arthritis [abstract]. Program of the 61st Annual Meeting of The American College of Rheumatology, Washington DC, 1997. p. S78.
8. 8. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastgenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest 1998;102:274-82.
9. 9. Arend WP, Dayer J-M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-15.
10. 10. Miyasaka N, Sato K, Goto M, Sasano M, Natsuyama M, Inoue K, et al. Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients: possible involvement in joint destruction. Arthritis Rheum 1988;31:480-6.
11. 11. Kitajima I, Nakajima T, Imamura T, Takasaki I, Kawahara K, Okano T, et al. Induction of apoptosis in murine clonal osteoblasts expressed by human T-cell leukemia virus type I tax by NF-κB and TNF-α. J Bone Miner Res 1996;11:200-10.
12. 12. Kitajima I, Soejima Y, Takasaki I, Beppu H, Tokioka T, Maruyama I. Ceramide-induced nuclear translocation of NF-κB is a potential mediator of the apoptotic response to TNF-α in murine clonal osteoblasts. Bone 1996;19:263-70.
13. 13. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Koji T, Urayama S, et al. Fas and Fas ligand interaction is necessary for human osteoblast apoptosis. J Bone Miner Res 1997; 12:1637-46.
14. 14. Nakashima T, Sasaki H, Tsuboi M, Kawakami A, Fujiyama K, Kiriyama T, et al. Inhibitory effect of glucocorticoid for osteoblasts apoptosis induced by activated peripheral blood mononuclear cells. Endocrinology. 1998;139:2032-40.
15. 15. Firestein GS, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995;96:1631-8.
16. 16. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Kawabe Y, Aoyagi T, et al. Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor β1. Arthritis Rheum 1996;39:1267-76.
17. 17. Tsuboi M, Eguchi K, Kawakami A, Matsuoka N, Kawabe Y, Aoyagi T, et al. Fas antigen expression on synovial cells was down-regulated by interleukin Iβ. Biochem Biophys Res Commun 1996;218:280-5.
18. 18. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Kawabe Y, Ishikawa N, et al. Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro. Endocrinology 1996;137:3163-9.
19. 19. Anderson P, Nagler-Anderson C, O'Brien C, Levine H, Watkins S, Slayter HS, et al. A monoclonal antibody reactive with a 15kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ lymphocytes. J Immunol 1990;144:574-82.
20. 20. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;39:271-9.
21. 21. Kameda T, Ishikawa H, Tsutsui T. Detection and characterization of apoptosis in osteoclasts in vitro. Biochem Biophys Res Commun 1995;207:753-60.
22. 2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem Biophys Res Commun 1996;220:515-9.
23. 23. Black KS, Mundy GR, Garrett IR. Interleukin 6 causes hypercalcemia in vivo and enhances the bone resorbing potency of interleukin 1 and tumor necrosis factor by two orders of magnitude in vitro. J Bone Miner Res 1990;5(suppl 2):S271.
24. 24. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-6.
25. 25. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β1. Nat Med 1996;2:1132-6.
26. 26. Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 1987;138:1464-8.
27. 27. Itoh N, Tsujimoto Y, Nagata S. Effect of Bcl-2 on Fas antigen-mediated cell death. J Immunol 1993;151:621-7.
28. 28. Allsopp TE, Wyatt S, Paterson HF, Davies AM. The protooncogene Bcl-2 can selectively rescue neurotrophic factor-dependent neurones from apoptosis. Cell 1993;73:295-307.
29. 29. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 1990;144:3602-10.
30. 30. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells: induction and modulation of sensitivity by cytokines. J Clin Invest 1994;94:954-64.
31. 31. Owen-Schaub LB, Radinsky R, Kruzel E, Berry K, Yonehara S. Anti-Fas on nonhematopoitic tumors: levels of Fas/APO-1 and Bcl-2 are not predictive of biological responsiveness. Cancer Res 1994;54:1580-6.
32. 32. Enari M, Talanian RV, Wong WW, Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 1996;380:723-6.
33. 33. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-78.
34. 34. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995;154:3806-13.
35. 35. Asahara H, Hasunuma T, Kobata T, Yagita H, Okumura K, Inoue H, et al. Expression of Fas antigen and Fas ligand in the rheumatoid synovial tissue. Clin Immunol Immunopathol 1996;81:27-34.
36. 36. Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 1995;14:1129-35.
37. 37. Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995;182:1777-83.
38. 38. Nakano Y, Watanabe K, Morimoto I, Okada Y, Ura K, Sato K, et al. Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein stimulated osteoclast formation in mice. J Bone Miner Res 1994;9:1533-9.